company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24019000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24019000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24019000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4193000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15799000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19992000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4027000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11206000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,188000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,690000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10328000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6301000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6301000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6301000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6301000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57166000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57166000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57300000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:11:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21054000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21054000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21048000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5410000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19365000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24775000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3727000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10741000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,93000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-234000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10882000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14609000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1082000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15691000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15691000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15691000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60400000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60400000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60400000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 08:50:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23576000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23576000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2538000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2538000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21038000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5076000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14905000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19981000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1057000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10231000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,81000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-39000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10189000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9132000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9150000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9150000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9150000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68098000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68098000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,70400000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 17:07:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27210000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,0.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27210000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,500000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,500000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26710000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5539000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17135000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22674000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4036000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10330000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,109000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,53000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10168000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6132000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6132000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6132000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6132000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,83200000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,83200000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,87600000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 17:06:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24601000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24601000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24599000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6413000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20227000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26640000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2041000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10589000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,70000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,211000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10308000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12349000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12349000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12349000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12349000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86749000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,86749000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,88200000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 08:50:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21214000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,5044000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26258000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26255000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7198000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21564000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28762000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2507000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6586000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,61000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,396000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6129000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8636000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8636000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8636000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8636000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,81279000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,81279000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,80600000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22924000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22924000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22924000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7770000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20199000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27969000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5045000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5534000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,84000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-68000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5518000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10563000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10563000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10563000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10563000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86850000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,86850000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,88000000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 17:07:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28517000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,25000000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53517000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,53517000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9670000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32641000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,42311000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11206000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4467000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,76000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,540000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3851000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7355000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7355000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7355000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7355000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86903000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,91470000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,91900000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 17:09:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27012000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,7000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27019000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27019000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8329000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17957000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26286000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,733000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4444000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,64000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,323000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4057000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3324000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3324000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3324000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3324000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86947000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,86947000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,83100000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 08:40:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27191000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-7000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27184000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27184000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11160000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24042000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35202000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8018000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3753000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,72000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-504000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4185000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12203000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12203000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12203000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12203000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86999000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,86999000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,85200000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25434000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25434000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,65000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,65000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25369000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14205000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15695000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29900000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4531000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3395000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,55000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,75000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3265000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7796000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7796000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7796000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7796000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,88402000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,88402000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,86600000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:35:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,36505000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,0.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,36505000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,473000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,473000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,36032000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14465000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30888000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,45353000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9321000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3034000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,58000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-88000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3064000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12385000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12389000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12389000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12389000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,97321000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,97321000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,95300000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:09:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39166000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,36000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39202000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1077000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1077000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38125000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17558000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18798000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36356000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1769000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2959000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,108000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2856000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1087000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1087000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1087000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1087000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102227000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,102227000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,108700000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q3,2013-07-01,2013-09-30,2013-11-06 08:40:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,54451000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,54451000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1981000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1981000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,52470000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21842000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20040000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41882000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10588000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2550000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,123000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-215000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2642000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7946000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,178000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7768000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7768000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7768000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,97750000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,97750000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,96500000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,44040000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,44040000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1877000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1877000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,42163000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24554000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20557000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,45111000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2948000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4035000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,121000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,297000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3617000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6565000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6576000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6576000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6576000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,103612000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,103612000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,109600000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 08:35:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,56127000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,56127000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2737000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2737000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,53390000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,26449000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21151000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47600000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5790000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3648000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,103000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3535000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2255000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,263000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1992000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1992000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1992000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106807000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,110503000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,99600000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 17:16:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,57200000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,57200000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3180000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3180000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,54020000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,28139000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24530000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52669000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1351000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3364000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,97000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3276000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1925000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,221000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2146000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2146000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2146000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,107312000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,107312000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,107300000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q3,2014-07-01,2014-09-30,2014-11-10 16:30:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,66695000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,66695000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6854000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6854000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,59841000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,35113000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23871000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,58984000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,857000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2681000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,97000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,23000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2561000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1704000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,271000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1975000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1975000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1975000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106341000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,106341000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,108800000.0
NPS Pharmaceuticals Inc ,NPSP,,0000890465,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
